Procter & Gamble Form 144 - Insider Sale of 376 Shares
Rhea-AI Filing Summary
Form 144 notice for Procter & Gamble (PG) shows a proposed sale of 376 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $58,244.28 and approximately 2,342,371,488 shares outstanding. The securities were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company and payment was recorded on 08/18/2025. No securities of the issuer were reported sold by the filer in the past three months. The filer affirms they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider sale notice: small block from a performance award, compliant with Rule 144 filing requirements.
This Form 144 documents a planned disposition of 376 shares valued at $58,244.28, acquired the prior day under a performance stock program. For a large-cap issuer like Procter & Gamble, the size of this sale is immaterial to outstanding shares and unlikely to affect market perception. The filing meets disclosure norms for an affiliate disposing of restricted securities under Rule 144; it contains acquisition date, broker, amount, and planned sale date.
TL;DR Governance-compliance view: standard bookkeeping of an insider award sale with appropriate representations.
The notice includes the required representation that the seller is unaware of undisclosed material adverse information and identifies the broker and planned sale date. There are no reported prior sales in the past three months by this filer, which reduces concerns about concentrated disposal. No governance red flags or material deviations from Rule 144 disclosure requirements are apparent from the submitted content.